At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 181 enrolled

Drug / intervention

azathioprine +1 moredrug

Likely dose

azathioprine 2mg/kgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00321906

NCT00321906Phase 4Completed

Compare CT.gov

Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen Versus Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation

University of Chicago·interventional·Posted May 4, 2006·Updated Sep 21, 2016

In Brief

A Phase 4 clinical trial evaluating azathioprine and sirolimus for Delayed Graft Function and Acute Graft Rejection. Completed, enrolled 181 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the safety and effectiveness of two different anti-rejection drug regimens.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDelayed Graft Function, Acute Graft Rejection

CountriesUnited States

CollaboratorsAstellas Pharma Inc, Loyola University, University of Florida, University of Pennsylvania, Baylor College of Medicine, Ochsner Health System, Columbia University, University of Wisconsin, Madison

Timeline

Phase 4CompletedFinished

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartApr 2002

First PostedMay 2006

Primary CompletionAug 2011

TodayJul 2026

First PostedMay 4, 2006

Enrollment StartApr 1, 2002

Primary CompletionAug 1, 2011

TodayJul 2, 2026

Enrollment to primary: 9.3 yearsPosted 20.2 years ago

Interventions

azathioprinedrug

azathioprine 2mg/kg

sirolimusdrug

sirolimus 2-4mg daily